Avenue Therapeutics shares are trading lower after the company reported worse-than-expected Q3 EPS results
Avenue Therapeutics, Inc. 0.00%
Avenue Therapeutics, Inc. ATXI | 1.72 | 0.00% |
Avenue Therapeutics shares are trading lower after the company reported worse-than-expected Q3 EPS results